![Tessio Rebello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tessio Rebello is Vice President of Clinical Affairs for VIRxSYS Corp.
Prior to joining VIRxSYS, he served as Director of Clinical Development for United Therapeutics Corp.
and as Head of the Cardiovascular Division for Sigma-Tau Pharmaceuticals, Inc. Dr. Rebello received a Bachelor of Science degree from the University of Liverpool and a PhD from the University of London.
| Companies | Position | End |
|---|---|---|
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology Develops gene based therapies | Chief Tech/Sci/R&D Officer | 04/05/2014 |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Corporate Officer/Principal | - |
| UNITED THERAPEUTICS CORPORATION | President | 21/05/2009 |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
United Therapeutics Corp.
 United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology Develops gene based therapies | Health Technology |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
